Abhishek Sehrawat1
1Radiodiagnosis & Imaging, All India Institute of Medical Sciences, Bhopal, India
Synopsis
Motivation: To evaluate the role that MR Spectroscopy and MR Perfusion play in characterizing breast masses on MR Mammograms with HPE correlation.
Goal(s):
- To compare the findings of the Histopathological Evaluation (HPE) with the radiological diagnosis.
- To evaluate the role that MR Spectroscopy and MR Perfusion play in the identification of breast masses.
Approach: 160 patients were included in prospective research design for eight months.
Patients with k/c/o carcinoma, sono-mammography, post-operative evaluation, and screening mammography were included.
Results: MRI diagnosis and histopathological results correlated in 86.1% patients. Dynamic Contrast Enhanced MR perfusion kinetics have been highly sensitive in distinguishing benign and malignant lesions.
Impact: MR mammography has been demonstrated that MR Perfusion is extremely sensitive in identifying benign from malignant breast lesions. In order to provide sufficient information to differentiate between breast tumors, MR Spectroscopy has proven useful adjunct to MR Perfusion.
Introduction : Worldwide, breast cancer is a common malignancy. The World Cancer Research Fund reports that breast cancer is the most common malignancy among women worldwide to receive a diagnosis. Breast MRI data can help with breast disease diagnosis, staging, and management, which can lead to more precise treatment choices and better patient outcomes. It has been discovered that MR mammography is a useful technique for separating worrisome breast tumors from benign ones.
Objectives : - Gathering information about MRI mammography exams from PACS in the past
- To carry out post-processing and assist in the characterisation of breast masses using spectroscopy's metabolite data and Perfusion's kinetic curve.
- To compare the findings of the Histopathological Evaluation (HPE) with the radiological diagnosis.
- To evaluate the role that MR Spectroscopy and MR Perfusion play in characterizing breast masses.
Method :160 patients were included in the prospective study design.
Study duration: Eight months.
Patients with k/c/o carcinoma, suspicious lesions on x-ray and sono-mammograms, post-operative evaluation, and screening mammography are the inclusion criteria.
Exclusion standards: Individuals whose renal parameters are elevated
Results summary: Previous research has shown that MR mammography can distinguish between benign and malignant breast lesions with a sensitivity of 85–100% and a specificity of 50–85%.It is clear from this study that the morphological characteristics of breast lesions, the pattern of contrast enhancement in the lesions, and the Dynamic Contrast Enhanced MR perfusion kinetics have been highly sensitive in differentiating between benign and malignant lesions. In this study, MRI diagnosis and histopathological results correlated in 86.1% of patients.
Conclusion : The MR mammography proved useful in differentiating between benign and malignant breast lesions. It has been demonstrated that MR Perfusion is extremely sensitive in identifying benign from malignant breast lesions. In order to provide sufficient information to differentiate between benign and malignant breast lesions, MR Spectroscopy has proven to be a useful adjunct to MR Perfusion.
Acknowledgements
No acknowledgement found.References
No reference found.